Literature DB >> 21618250

The peak-standardized uptake value (P-SUV) by preoperative positron emission tomography-computed tomography (PET-CT) is a useful indicator of lymph node metastasis in gastric cancer.

Hyeon Hwa Oh1, Sang Eok Lee, In Seok Choi, Won Jun Choi, Dae Sung Yoon, Hyun Sik Min, Yu Mi Ra, Ju Ik Moon, Yun Hee Kang.   

Abstract

BACKGROUND AND OBJECTIVES: Little data is currently available on the usefulness of peak-standardized uptake value (P-SUV) by positron emission tomography-computed tomography (PET-CT) in gastric cancer. The purpose of the present study was to evaluate the value of PET-CT for the preoperative evaluation of patients with gastric cancer. The aim of this study was to assess the relation of between primary tumor P-SUV, as determined by preoperative PET-CT, and lymph node metastasis in gastric cancer.
METHODS: From December 2007 to March 2010, we analyzed the PET-CT of 147 patients that underwent gastrectomy for gastric cancer. P-SUV in PET-CT were measured by single nuclear medicine physician. Statistical analysis was performed to determine relations between clinicopathologic parameters including P-SUV and lymph node metastasis using the chi-square test, the independent t-test, and using logistic regression analysis.
RESULTS: Age, tumor depth, tumor size, and lymph node metastasis were found to be associated with primary tumor P-SUV by PET-CT (P=0.009, <0.001, <0.001, and <0.001, respectively). No association was found between P-SUV and tumor histology or tumor location (P=0.099). Advanced gastric cancer was found to have a higher P-SUV than early gastric cancer, and a higher P-SUV was found to be associated with lymph node metastases by both univariate and multivariate analysis.
CONCLUSIONS: P-SUV of primary tumor could be an independent indicator of lymph node metastasis in gastric cancer. Gastric surgeons should pay more attention to the dissection of lymph nodes when primary tumors have higher P-SUV values by PET-CT.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21618250     DOI: 10.1002/jso.21985

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  15 in total

1.  Feasibility of FDG-PET/CT for the initial diagnosis of papillary thyroid cancer.

Authors:  Heejin Kim; Kyung Jin Na; Jae Hyuk Choi; Byeong-Cheol Ahn; Dongbin Ahn; Jin Ho Sohn
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-14       Impact factor: 2.503

2.  Pretreatment F-18 FDG PET/CT Parameters to Evaluate Progression-Free Survival in Gastric Cancer.

Authors:  Jeonghun Kim; Seok Tae Lim; Chang Ju Na; Yeon-Hee Han; Chan-Young Kim; Hwan-Jeong Jeong; Myung-Hee Sohn
Journal:  Nucl Med Mol Imaging       Date:  2013-11-28

3.  Role of ¹⁸F-FDG PET/CT in the prediction of gastric cancer recurrence after curative surgical resection.

Authors:  Jeong Won Lee; Sang Mi Lee; Moon-Soo Lee; Hyeong Cheol Shin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06-07       Impact factor: 9.236

4.  Prognostic value and clinical correlations of 18-fluorodeoxyglucose metabolism quantifiers in gastric cancer.

Authors:  Kinga Grabinska; Maciej Pelak; Jerzy Wydmanski; Andrzej Tukiendorf; Andrea d'Amico
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

5.  Preoperative prediction of the pathological stage of advanced gastric cancer by 18F-fluoro-2-deoxyglucose positron emission tomography.

Authors:  Kota Yamada; Naoki Urakawa; Shingo Kanaji; Hiroshi Hasegawa; Masashi Yamamoto; Kimihiro Yamashita; Takeru Matsuda; Taro Oshikiri; Satoshi Suzuki; Yoshihiro Kakeji
Journal:  Sci Rep       Date:  2022-07-05       Impact factor: 4.996

6.  [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of gastric cancer: comparison with [18F]FDG PET/CT.

Authors:  Rong Lin; Zefang Lin; Zhenying Chen; Shan Zheng; Jiaying Zhang; Jie Zang; Weibing Miao
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-04-25       Impact factor: 10.057

7.  Assessment of (18)F-fluorodeoxyglucose positron emission tomography combined with computed tomography in the preoperative management of patients with gastric cancer.

Authors:  Tsutomu Namikawa; Takehiro Okabayshi; Munenobu Nogami; Yasuhiro Ogawa; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  Int J Clin Oncol       Date:  2013-07-24       Impact factor: 3.402

8.  68Ga-DOTA-FAPI-04 PET/MR in the Evaluation of Gastric Carcinomas: Comparison with 18F-FDG PET/CT.

Authors:  Chunxia Qin; Fuqiang Shao; Yongkang Gai; Qingyao Liu; Weiwei Ruan; Fang Liu; Fan Hu; Xiaoli Lan
Journal:  J Nucl Med       Date:  2021-04-16       Impact factor: 11.082

9.  Preoperative Prediction of Cervical Lymph Node Metastasis Using Primary Tumor SUVmax on 18F-FDG PET/CT in Patients with Papillary Thyroid Carcinoma.

Authors:  Ji-hoon Jung; Choon-Young Kim; Seung Hyun Son; Do-Hoon Kim; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

10.  Recent chemotherapy reduces the maximum-standardized uptake value of 18F-fluoro-deoxyglucose positron emission tomography in colorectal cancer.

Authors:  Minjong Lee; Tae Sung Yeum; Ji Won Kim; Sohee Oh; Shin Ae Lee; Hong Ran Moon; Young Hoon Choi; Yoo Min Han; Ji Min Choi; Dong Kee Jang
Journal:  Gut Liver       Date:  2014-05       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.